Recombinant human basic fibroblast growth factor capsule (EssexBio)

重组人碱性成纤维细胞生长因子胶囊（亿胜）

Report date: 2024/11/20 09:57:24

Base Information

Drug NameRecombinant human basic fibroblast growth factor capsule (EssexBio)
Drug Alias NameRecombinant human basic fibroblast growth factor (EssexBio)rh-bFGF (EssexBio)贝复适
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionFibroblast growth factor receptors agonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsStomach Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesZhuhai Essex Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZhuhai Essex Bio-Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsStomach Ulcer

Other Information

ATC CodeN/A
Related LinksN/A